Day: August 14, 2023

Mined 106.6 Bitcoins in the Second Quarter of 2023 at an Average Market Revenue Value of Approximately $27,900 per Bitcoin Completed Acquisition of Symbiont.io Assets; Advancing Strategic Relationships to Leverage its Assembly™ Financial Services Blockchain Enterprise Platform Reports Working Capital of Approximately $5.5 Million and LM Funding Stockholders’ Equity of $39.9 Million ($2.72 per share) as of June 30, 2023 Conference Call to Be Held Today at 11:00 am ET TAMPA, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today provided a business update and reported financial results for the quarter ended June 30, 2023. Operational HighlightsApproximately 5,230 Bitcoin mining machines...

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.71 per share for the fiscal second quarter ended August 31, 2023, an increase of $0.01 from $0.70 per share in the prior fiscal first quarter, and the fourteenth quarterly dividend increase in a row. This dividend is payable on September 28, 2023, to all stockholders of record at the close of business on September 14, 2023. “The impact of the absolute level and continued increase in interest rates on our largely floating rate assets, when combined with the growth of our overall portfolio, its resilient performance and our largely fixed rate liabilities, have resulted in record earnings,” said Christian...

Announced today that all 3 patients (100% response rate) treated with ELX-02 showed an improvement in podocyte foot process effacement post-treatment in kidney biopsies assessed by electron microscopy, demonstrating the disease-modifying effect of ELX-02 Announced achievement of remission in one patient in Phase 2 clinical study of ELX-02 for the treatment of Alport syndrome and decision to advance ELX-02 into a pivotal trial in Alport syndrome Highlighted significant unmet need in the treatment of Alport syndrome and additional positive data from Phase 2 clinical study evaluating ELX-02 in KOL event Received Food and Drug Administration (FDA) Investigational New Drug clearance to begin single ascending dose (SAD) study of ZKN-013; first subject intended to be dosed by the end of 2023 Raised $3.4M in net proceeds through “at-the-market”...

– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and in first EU country, Austria, in Q2 – Multiple supportive studies show the clear economic benefits of using Maoz related to increased crop yield and cost and operational efficiencies -Additional studies of Grace Breeding’s WDS bio-activator for foliar application, branded ProMagen™, continues to demonstrate boosted while enhancing plant resilience and disease tolerance compared to standard, synthetic fertilizers – Global brand names secured for both products, with partnerships and commercial efforts advancing REHOVOT, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) — Grace Breeding Ltd. (the “Company” or “Grace Breeding”) (TASE: GRAC), a forward-thinking AgClimateTech...

NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided a corporate update and financial results for the second quarter ending June 30, 2023. Q2 2023 Financial HighlightsNet loss of $14.1 million and per share amount of $0.05 for the quarter ended June 30, 2023 Total cash of approximately $20.0 million at June 30, 2023Registered Direct OfferingRegistered Direct Offering at a price of $2.00, a premium of 82% to the TMC closing share price on August 11, with expected gross proceeds of approximately $27 million based on existing commitments The Registered Direct Offering on significantly above-market standard terms is led by largest TMC shareholder ERAS Capital, strategic partner...